These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 23258480)
1. Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma. Cheng N; Li Y; Han ZG Hepatology; 2013 May; 57(5):1906-18. PubMed ID: 23258480 [TBL] [Abstract][Full Text] [Related]
2. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability. Liu Y; Zhang JB; Qin Y; Wang W; Wei L; Teng Y; Guo L; Zhang B; Lin Z; Liu J; Ren ZG; Ye QH; Xie Y Hepatology; 2013 Aug; 58(2):692-705. PubMed ID: 23505027 [TBL] [Abstract][Full Text] [Related]
3. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma. Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637 [TBL] [Abstract][Full Text] [Related]
4. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion. Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997 [TBL] [Abstract][Full Text] [Related]
5. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling. Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982 [TBL] [Abstract][Full Text] [Related]
6. PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK. Zhou Q; Zhou Q; Liu Q; He Z; Yan Y; Lin J; Chen Z; He C; Mao K; Wang J; Zhou Z; Xiao Z; Zhang J Theranostics; 2020; 10(22):10345-10359. PubMed ID: 32929353 [No Abstract] [Full Text] [Related]
7. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma. Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318 [TBL] [Abstract][Full Text] [Related]
8. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2. Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656 [TBL] [Abstract][Full Text] [Related]
9. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734 [TBL] [Abstract][Full Text] [Related]
10. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition. Chung KY; Cheng IK; Ching AK; Chu JH; Lai PB; Wong N Hepatology; 2011 Jul; 54(1):307-18. PubMed ID: 21520196 [TBL] [Abstract][Full Text] [Related]
11. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis. Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479 [TBL] [Abstract][Full Text] [Related]
12. RNA interference against cancer/testis genes identifies dual specificity phosphatase 21 as a potential therapeutic target in human hepatocellular carcinoma. Deng Q; Li KY; Chen H; Dai JH; Zhai YY; Wang Q; Li N; Wang YP; Han ZG Hepatology; 2014 Feb; 59(2):518-30. PubMed ID: 23929653 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555 [TBL] [Abstract][Full Text] [Related]
14. PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma. Zhang H; Sheng C; Yin Y; Wen S; Yang G; Cheng Z; Zhu Q Cancer Lett; 2015 Oct; 367(1):49-57. PubMed ID: 26188282 [TBL] [Abstract][Full Text] [Related]
15. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma. Tian H; Ge C; Li H; Zhao F; Hou H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J Hepatology; 2014 Apr; 59(4):1459-70. PubMed ID: 24214128 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Chang RM; Yang H; Fang F; Xu JF; Yang LY Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302 [TBL] [Abstract][Full Text] [Related]
17. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma. Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532 [TBL] [Abstract][Full Text] [Related]
18. Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling. Liu L; Dai Y; Chen J; Zeng T; Li Y; Chen L; Zhu YH; Li J; Li Y; Ma S; Xie D; Yuan YF; Guan XY Hepatology; 2014 Feb; 59(2):531-43. PubMed ID: 23929794 [TBL] [Abstract][Full Text] [Related]
19. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice. Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424 [TBL] [Abstract][Full Text] [Related]
20. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway. Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]